REG - Zotefoams PLC - Group CFO succession

ZotefoamsAnnouncement

Mon 14:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250922:nRSV2912Aa&default-theme=true

RNS Number : 2912A  Zotefoams PLC  22 September 2025

Zotefoams plc

('Zotefoams' or 'Group')

 

Group CFO succession

22 September 2025 - Further to the announcement of 30 April 2025 regarding the
succession of the Group Chief Financial Officer, Zotefoams confirms that Nick
Wright has joined the business as CFO Designate and has been appointed to the
Board as Executive Director.

 

Nick will assume the role of CFO on 1 November 2025, following the retirement
of Gary McGrath on 31 October 2025.

 

Enquiries:

 Zotefoams plc            +44 (0) 208 664 1600
 Ronan Cox, Group CEO
 Gary McGrath, Group CFO

 IFC Advisory             +44 (0) 203 934 6630
 Graham Herring

 Tim Metcalfe

 Zach Cohen

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in supercritical fluid foam
technology, delivering optimal material solutions for the benefit of society.
Utilising a variety of unique manufacturing processes, including
environmentally friendly nitrogen expansion for lightweight AZOTE® and
ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide
across three market verticals, Consumer & Lifestyle, Transport & Smart
Technologies, and Construction & Other Industrial. Zotefoams uses its own
materials to manufacture T-FIT® advanced insulation for demanding industrial
markets.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), and foam products
conversion in Oklahoma, USA and Jiangsu Province, China (T-FIT).

 

www.zotefoams.com

 

AZOTE®, ZOTEK® and T-FIT® are registered trademarks of Zotefoams plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOASEEFDEEISEDU



            Copyright 2019 Regulatory News Service, all rights reserved